Affyimmune Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Affyimmune Therapeutics

Access the complete profile.

Affyimmune Therapeutics Fast Facts

Revenue	$1 - $10 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	621511 Medical Laboratories
Address	22 Strathmore Rd Suite 255 Natick, MA 01760

Note: Revenues for privately held companies are statistical evaluations.


Affyimmune Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Affyimmune Therapeutics's annual revenues are $1 - $10 million (see exact revenue data)
• What industry is the company in?
  • Affyimmune Therapeutics is classified as operating in the Medical Laboratories industry, NAICS Code 621511.

Affyimmune Therapeutics Annual Revenue and Growth Rate

Affyimmune Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$1 - $10 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Affyimmune Therapeutics's revenues are gauged from an analysis of company filings.

Affyimmune Therapeutics's Income Statement (based on Industry Averages)

Affyimmune Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Affyimmune Therapeutics has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
November 28, 2018	2	54%	$15 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Affyimmune Therapeutics is developing and marketing. Affyimmune Therapeutics doesn't have any recent trademark applications, indicating Affyimmune Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark

Date

AFFYIMMUNE THERAPEUTICS cells for medical or clinical use; kits comprised of cells and pharmaceuticals for medical or clinical use; pharmaceutical compositions for the treatment of cancer and for immunotherapy; biological compositions for the treatment of cancer and for immunotherapy; cellular immunotherapy compositions, namely, compositions, namely, engineered chimeric antigen receptors (CARs) and t-cell receptors (TCRs)

03/24/2017

See all trademarks and details in the Full Report.

Market Share of Affyimmune Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Affyimmune Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
PHYSICIANS IMMUNODIAGNOSTIC LABORATORY	Burbank, CA	100
ACCU REFERENCE MEDICAL LAB LIMITED LIABILITY	Linden, NJ	100
CENTOGENE US	Cambridge, MA	88
LATARA ENTERPRISE	Pomona, CA	61
TELIGENT PHARMA	Vineland, NJ	46
COVID CLINIC	Huntington Beach, CA	37
VIKOR SCIENTIFIC	Charleston, SC	33
BIOTHERANOSTICS	San Diego, CA	31
SHERMAN-ABRAMS LABORATORY	Brooklyn, NY	31

Nearby Competitors

These companies are similar in business line and location to Affyimmune Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PSYCHEMEDICS	Acton, MA	100
HCT	Ashland, MA	28
VENTURE FORWARD	Framingham, MA	27
BRENDAN BIOSCIENCE	Hopedale, MA	21
KBMO DIAGNOSTICS	Hopedale, MA	21
AFFYIMMUNE THERAPEUTICS	Natick, MA	19

Future Competition: Affyimmune Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Affyimmune Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)